• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Research Project

Project/Area Number 22790633
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionTokyo Medical and Dental University

Principal Investigator

NAKAGAWA Mina  東京医科歯科大学, 医学部附属病院, 助教 (30401342)

Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsIFN治療抵抗性 / HCVコア変異株 / インターロイキン(IL)-6 / 小胞体(ER)ストレス / HCVレプリコンシステム / HCVコア蛋白変異株 / インターフェロン(IFN)治療抵抗性 / インターロイキン(IL)6 / SOCS3
Research Abstract

Here we investigated mechanisms of difference in the response to alpha interferon(IFN) by using HCV cell culture with HCV core mutant R70Q, R70H, and L91M virus clones The expression level of an interferon signal attenuator, SOCS3, was significantly higher for the R70Q, R70H, and L91M mutants than for the wild type. Interleukin 6(IL-6), which upregulates SOCS3, was significantly higher for the R70Q, R70H, and L91M mutants than for the wild type, suggesting interferon resistance, possibly through IL-6-induced, SOCS3-mediated suppression of interferon signaling. Expression levels of endoplasmic reticulum(ER) stress proteins were significantly higher in cells transfected with a core mutant than in those transfected with the wild type. The HCV-2b/JFH1chimeric virus, which was constructed in our laboratory, able to infect Huh7. 5. 1 cells and was significantly more sensitive to IFN than JFH1. The IFN resistance of JFH1 cells was negated by siRNA-knock down of SOCS3 expression and by pretreatment with anti-IL6 antibody. These data suggest that these differences of IFN sensitivity of HCV may be attributable to the sequences of HCV structural proteins and can be determined by SOCS3 and IL-6 expression levels, which might be induced by ER etress.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • Research Products

    (67 results)

All 2012 2011 2010 Other

All Journal Article (43 results) (of which Peer Reviewed: 35 results) Presentation (22 results) Book (1 results) Remarks (1 results)

  • [Journal Article] Identification of NovelN-(Morpholine-4-Carbonyloxy) Amidine Compounds as Potent Inhibitors against Hepatitis C Virus Replication2012

    • Author(s)
      Kusano-Kitazume A, Nakagawa M, et. al
    • Journal Title

      Antimicrob Agents Chemother

      Volume: 56 Pages: 1315-23

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Age and totalribavirin dose are independent predictors ofrelapse after interferon therapy in chronichepatitis C revealed by data mining analysis2012

    • Author(s)
      Kurosaki M, Nakagawa M, et. al
    • Journal Title

      Antivir Ther

      Volume: 17 Pages: 35-43

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of the complete open reading frame of hepatitis Cvirus in genotype 2a infection reveals criticalsites influencing the response to peginterferonand ribavirin therapy2011

    • Author(s)
      Kadokura M, Nakagawa M, et. al
    • Journal Title

      Hepatol Int

      Volume: 5 Pages: 789-99

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the responseto peginterferon and ribavirin therapy2011

    • Author(s)
      Kadokura M, Nakagawa M, et. al
    • Journal Title

      PLoS One

      Volume: 6

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Analysis ofinterferon signaling by infectious hepatitis C virusclones with substitutions of core amino acids 70 and 912011

    • Author(s)
      Funaoka Y, Nakagawa M, et. al
    • Journal Title

      J Virol

      Volume: 85 Pages: 5986-94

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effect of triterpenoid compound with or without interferon-alpha on Hepatitis C virus infection2011

    • Author(s)
      Watanabe T, Nakagawa M, et. al
    • Journal Title

      Antimicrob Agent Chemother

      Volume: 55 Pages: 2537-45

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum interleukin-6 levelscan predict resistance to treatment of chronichepatitis C infection with pegylated-interferonalpha 2b plus ribavirin2011

    • Author(s)
      Nakagawa M, et. al
    • Journal Title

      Antiviral Therapy

      Volume: 16 Pages: 1081-1091

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Sequences in the interferon sensitivity-determining region andcore region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin : data mininganalysis2011

    • Author(s)
      Kurosaki M, Nakagawa M, et. al
    • Journal Title

      J Med Virol

      Volume: 83 Pages: 445-52

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice2011

    • Author(s)
      Onozuka I, Nakagawa M, et. al
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 406 Pages: 134-140

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Association of IL 28B polymorphism with response topegylated-interferon alpha plus ribavirin combination therapy in patients with chronic genotype 2 hepatitis C2011

    • Author(s)
      Nakagawa M, et. Al
    • Journal Title

      J Medical Virol

      Volume: 83 Pages: 871-878

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Studieson virus kinetics using infectious fluorescence-tagged hepatitis C virus cellculture2011

    • Author(s)
      Yamamoto M, Nakagawa M, et. al
    • Journal Title

      Hepatology Research

      Volume: 41 Pages: 258-69

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Pretreatment Prediction of Response to Pegylated-Interferon Plus Ribavirin for Chronic Hepatitis C using Genetic Polymorphism in IL28B and Viral Factors2011

    • Author(s)
      Kurosaki M, Nakagawa M, et. al
    • Journal Title

      J Hepatol

      Volume: 54 Pages: 439-48

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cyclophilin inhibitors特集/ウイルス肝炎診療の変貌:近づく疾患克服2011

    • Author(s)
      中川美奈, ほか
    • Journal Title

      肝胆膵

      Volume: 62巻2号 Pages: 403-411

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum interleukin-6 levels can predict resistance to treatment of chronichepatitis C infection with pegylated-interferon alpha 2b plus ribavirin2011

    • Author(s)
      Ueyama M, Nakagawa M (equal contribution), et al
    • Journal Title

      Antiviral Therapy

      Volume: 16 Pages: 1089-1091

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b2011

    • Author(s)
      Sakamoto N, Nakagawa M, Azuma S, Watanabe M, et al.
    • Journal Title

      J Med Virol

      Volume: 83 Issue: 5 Pages: 871-878

    • DOI

      10.1002/jmv.22038

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 912011

    • Author(s)
      Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K,Watanabe M
    • Journal Title

      J Virol

      Volume: 85 Issue: 12 Pages: 5986-94

    • DOI

      10.1128/jvi.02583-10

    • Related Report
      2011 Annual Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors2011

    • Author(s)
      Kurosaki M, Sakamoto N, Nakagawa M, Watanabe M, et al.
    • Journal Title

      J Hepatol

      Volume: 54 Issue: 3 Pages: 439-448

    • DOI

      10.1016/j.jhep.2010.07.037

    • Related Report
      2011 Annual Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection2011

    • Author(s)
      Watanabe T, Sakamoto N, Nakagawa M, Azuma S, Watanabe M, et al.
    • Journal Title

      Antimicrob Agents Chemother

      Volume: 55(6) Issue: 6 Pages: 2537-2545

    • DOI

      10.1128/aac.01780-10

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture2011

    • Author(s)
      Yamamoto M, Sakamoto N, Nakamura T, Itsui Y, Nakagawa M, Nishimura-Sakurai Y, Kakinuma S, Azuma S, Kato T, Wakita T, Watanabe M
    • Journal Title

      Hepatol Res

      Volume: 41 Issue: 3 Pages: 258-269

    • DOI

      10.1111/j.1872-034x.2010.00771.x

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin : data mining analysis2011

    • Author(s)
      Kurosaki M, Sakamoto N, Nakagawa M, et al.
    • Journal Title

      J Med Virol

      Volume: 83 Issue: 3 Pages: 445-452

    • DOI

      10.1002/jmv.22005

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cyclophilin inhibitors2011

    • Author(s)
      中川美奈、坂本直哉、渡辺守
    • Journal Title

      肝胆膵

      Volume: 62巻2号 Pages: 403-411

    • Related Report
      2011 Annual Research Report
  • [Journal Article] Serum interleukin-6 levels can predict resistance to treatment of chronic hepatitis C infection with pegylated-interferon alpha 2b plus ribavirin.2011

    • Author(s)
      Ueyama M, Nakagawa M, et al
    • Journal Title

      Antiviral Therapy

      Volume: (In press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.2011

    • Author(s)
      Onozuka I, Nakagawa M, et al
    • Journal Title

      Biochem Biophys Res Commun

      Volume: (In press)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association of IL28B polymorphism with response to pegylated-interferon alpha plus ribavirin combination therapy in patients with chronic genotype 2 hepatitis C.2011

    • Author(s)
      Nakagawa M, et al
    • Journal Title

      J Medical Virol

      Volume: 83 Pages: 871-878

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The inhibitory effect of triterpenoid compound with or without interferon-alpha on Hepatitis C virus infection.2011

    • Author(s)
      Takako W, Nakagawa M, et al
    • Journal Title

      Antimicrobial Agents and Chemotherapy

      Volume: 55 Pages: 2537-2545

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture.2011

    • Author(s)
      Yamamoto M, Nakagawa M, et al
    • Journal Title

      Hepatology Research

      Volume: 41 Pages: 258-269

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ITPA gene variant protects against anemia induced by pegylated interferon-a and ribavirin therapy for Japanese patients with chronic hepatitis C2010

    • Author(s)
      Sakamoto N, Nakagawa M, et. al
    • Journal Title

      Hepatology Res

      Volume: 40 Pages: 1063-1071

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones2010

    • Author(s)
      Suda G, Nakagawa M, et. al
    • Journal Title

      Virology

      Volume: 407 Pages: 80-90

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cell cultureand in vivo analyses of cytopathic hepatitis Cvirus mutants2010

    • Author(s)
      Mishima K, Nakagawa M, et. al
    • Journal Title

      Virology

      Volume: 405 Pages: 361-369

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of HCV replication by a specific inhibitor ofserine-arginine-rich protein kinase2010

    • Author(s)
      Karakama Y, Nakagawa M, et. al
    • Journal Title

      Antimicrobial Agents and Chemotherapy

      Volume: 54 Pages: 3179-3186

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Mutations in the Interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin inpatients with chronic hepatitis C-1b infection2010

    • Author(s)
      Nakagawa M, et. al
    • Journal Title

      JGastroentero

      Volume: 45(6) Pages: 656-65

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] ホルモン・サイトカインから見た肝発癌機構の性差IL-6と肝炎・肝発癌2010

    • Author(s)
      植山真由美、中川美奈, ほか
    • Journal Title

      肝・胆・膵

      Volume: 60巻5号 Pages: 849-856

    • Related Report
      2011 Final Research Report
  • [Journal Article] C型肝炎の日常診療治療の適応、選択の実際2010

    • Author(s)
      筬島裕子、中川美奈, ほか
    • Journal Title

      medicina

      Volume: 47巻3号 Pages: 437-441

    • Related Report
      2011 Final Research Report
  • [Journal Article] HCVの複製・増殖機構と遺伝子型・遺伝子異変2010

    • Author(s)
      筬島裕子、中川美奈, ほか
    • Journal Title

      日本臨床

    • Related Report
      2011 Final Research Report 2010 Annual Research Report
  • [Journal Article] 肝疾患における血液生化学検査2010

    • Author(s)
      坂本直哉、中川美奈, ほか
    • Journal Title

      IL28B肝・胆・膵

      Volume: 60巻4号 Pages: 657-660

    • Related Report
      2011 Final Research Report
  • [Journal Article] ITPA gene variant protects against anemia induced by pegylated interferon-a and ribavirin therapy for Japanese patients with chronic hepatitis C2010

    • Author(s)
      Sakamoto N, Nakagawa M, et al
    • Journal Title

      Hepatology Research

      Volume: 40 Pages: 1063-1071

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants2010

    • Author(s)
      Mishima K, Nakagawa M, et al
    • Journal Title

      Virology

      Volume: 405 Pages: 361-369

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of HCV replication by a specific inhibitor of serine-arginine-rich protein kinase2010

    • Author(s)
      Karakama Y, Nakagawa M, et al
    • Journal Title

      Antimicrobial Agents and Chemotherapy

      Volume: 405 Pages: 3179-3186

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mutations in the Interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection2010

    • Author(s)
      Nakagawa M, et al
    • Journal Title

      J Gastroentero.

      Volume: 45 Pages: 656-665

    • NAID

      10027216778

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin : data mining analysis2010

    • Author(s)
      Kurosaki M, Nakagawa M, et al
    • Journal Title

      J Medical Virol

      Volume: 83 Pages: 445-452

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 【性差による肝胆膵疾患の臨床、病態、治療効果のDiscrepancy】ホルモン・サイトカインから見た肝発癌機構の性差IL-6と肝炎・肝発癌2010

    • Author(s)
      植山真由美、中川美奈, ほか
    • Journal Title

      肝胆膵

      Volume: 60 Pages: 849-856

    • Related Report
      2010 Annual Research Report
  • [Journal Article] 【ウイルス肝炎 日常診療のポイント】C型肝炎の日常診療 治療の適応、選択の実際2010

    • Author(s)
      筬島裕子、中川美奈, ほか
    • Journal Title

      medicina

      Volume: 47 Pages: 437-441

    • Related Report
      2010 Annual Research Report
  • [Journal Article] 肝疾患における血液生化学検査,IL28B2010

    • Author(s)
      坂本直哉、中川美奈, ほか
    • Journal Title

      肝胆膵

      Volume: 60 Pages: 657-660

    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎のインターフエロン治療抵抗性機序におけるIL-6の関与2011

    • Organizer
      第15回日本肝臓学会大会シンポジウム
    • Place of Presentation
      福岡
    • Year and Date
      2011-10-20
    • Related Report
      2011 Final Research Report
  • [Presentation] C型慢性肝炎のインターフエロン治療抵抗性機序におけるIL-6の関与2011

    • Author(s)
      中川美奈、坂本直哉
    • Organizer
      第15回日本肝臓学会大会
    • Place of Presentation
      福岡
    • Year and Date
      2011-10-20
    • Related Report
      2011 Annual Research Report
  • [Presentation] 高齢化社会のC型慢性肝炎対策における宿主・ウイルス遺伝子情報に基づく個別化治療の重要性2011

    • Organizer
      第47回日本肝臓学会総会パネルディスカッション
    • Place of Presentation
      東京
    • Year and Date
      2011-06-03
    • Related Report
      2011 Final Research Report
  • [Presentation] C型慢性肝炎のPEG-IFNα-2b/Ribavirin併用療法におけるITPA遺伝子の臨床的意義2011

    • Organizer
      第47回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-06-03
    • Related Report
      2011 Final Research Report
  • [Presentation] Genotype2b/JFH1キメラウイルス長期培養系を用いたIFN抵抗性株の解析2011

    • Organizer
      第47回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-06-03
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] 高齢化社会のC型慢性肝炎対策における宿主・ウイルス遺伝子情報に基個別化治療の重要性2011

    • Author(s)
      坂本直哉、中川美奈
    • Organizer
      第47回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-06-03
    • Related Report
      2011 Annual Research Report
  • [Presentation] C型慢性肝炎のインターフエロン治療抵抗性機序におけるIL-6の関与2011

    • Author(s)
      櫻井幸、中川美奈
    • Organizer
      第47回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-06-03
    • Related Report
      2011 Annual Research Report
  • [Presentation] IL-28B SNPs and HCV genetic profiles are significant predictors of PEG-interferon plus ribavirin treatment outcomes2010

    • Organizer
      The 7^<th> APASLSingle Topic Conference "Hepatitis C"
    • Year and Date
      2010-12-17
    • Related Report
      2011 Final Research Report
  • [Presentation] IL-28B SNPs and HCV genetic profiles are significant predictors of PEG-interferon plus ribavirin treatment outcomes2010

    • Author(s)
      Nakagawa M, et al
    • Organizer
      The 7^<th> APASL Single Topic Conference "Hepatitis C"
    • Place of Presentation
      Chiba
    • Year and Date
      2010-12-17
    • Related Report
      2010 Annual Research Report
  • [Presentation] ウイルスおよび宿主遺伝子情報に基づくC型慢性肝炎の治療戦略2010

    • Organizer
      第38回日本肝臓学会東部会パネルディスカッション
    • Place of Presentation
      東京
    • Year and Date
      2010-12-03
    • Related Report
      2011 Final Research Report
  • [Presentation] ウイルスおよび宿主遺伝子情報に基づくC型慢性肝炎の治療戦略2010

    • Author(s)
      中川美奈, ほか
    • Organizer
      第38回日本肝臓学会東部会
    • Place of Presentation
      東京
    • Year and Date
      2010-12-03
    • Related Report
      2010 Annual Research Report
  • [Presentation] IL28B遺伝子多型と治療抵抗性ウイルス変異からみたC型慢性肝炎の治療抵抗メカニズムの解析2010

    • Organizer
      第38回日本肝臓学会東部会シンポジウム
    • Place of Presentation
      東京
    • Year and Date
      2010-12-02
    • Related Report
      2011 Final Research Report
  • [Presentation] IL28B遺伝子多型と治療抵抗性ウイルス変異からみたC型慢性肝炎の治療抵抗メカニズムの解析2010

    • Author(s)
      中川美奈, ほか
    • Organizer
      第38回日本肝臓学会東部会
    • Place of Presentation
      東京
    • Year and Date
      2010-12-02
    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎患者におけるインターフェロン治療効果におけるインターロイキン-6(IL-6)の関与2010

    • Organizer
      第14回日本肝臓学会大会パネルディスカッション
    • Place of Presentation
      横浜
    • Year and Date
      2010-10-14
    • Related Report
      2011 Final Research Report
  • [Presentation] C型慢性肝炎患者におけるインターフェロン治療効果におけるインターロイキン-6(IL-6)の関与2010

    • Author(s)
      中川美奈, ほか
    • Organizer
      第14回日本肝臓学会大会、JDDW2010
    • Place of Presentation
      横浜
    • Year and Date
      2010-10-14
    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎のインターフェロン治療効果とIL28B遺伝子多型の解析2010

    • Organizer
      第14回日本肝臓学会大会ポスター
    • Place of Presentation
      横浜
    • Year and Date
      2010-10-13
    • Related Report
      2011 Final Research Report
  • [Presentation] C型慢性肝炎のインターフェロン治療効果とIL28B遺伝子多型の解析2010

    • Author(s)
      中川美奈, ほか
    • Organizer
      第14回日本肝臓学会大会、JDDW2010
    • Place of Presentation
      横浜
    • Year and Date
      2010-10-13
    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎のインターフェロン治療効果とIL28B遺伝子多型の解析2010

    • Organizer
      第46回日本肝臓学会総会一般演題
    • Place of Presentation
      山形
    • Year and Date
      2010-05-28
    • Related Report
      2011 Final Research Report
  • [Presentation] C型慢性肝炎のインターフェロン治療効果とIL28B遺伝子多型の解析2010

    • Author(s)
      中川美奈, ほか
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      山形
    • Year and Date
      2010-05-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] C型慢性肝炎のPEGインターフェロン治療効果と治療後発癌に関する検討2010

    • Author(s)
      植山真由美、中川美奈, ほか
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      山形
    • Year and Date
      2010-05-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] ウイルス遺伝子および宿主IL28B遺伝子情報を統合したC型慢性肝炎治療のオーダーメイド化2010

    • Organizer
      第46回日本肝臓学会総会シンポジウム
    • Year and Date
      2010-05-27
    • Related Report
      2011 Final Research Report
  • [Presentation] ウイルス遺伝子および宿主IL28B遺伝子情報を統合したC型慢性肝炎治療のオーダーメイド化2010

    • Author(s)
      坂本直哉、中川美奈, ほか
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      山形
    • Year and Date
      2010-05-27
    • Related Report
      2010 Annual Research Report
  • [Book] すべての内科医に役立つ肝疾患なるほどQ&A(Q5.Q13を担当)2011

    • Author(s)
      中川美奈, ほか
    • Publisher
      羊土社
    • Related Report
      2010 Annual Research Report
  • [Remarks] 本学消化器内科ホームページにて研究成果を紹介

    • Related Report
      2011 Final Research Report

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi